HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on Ekso Bionics Holdings (NASDAQ:EKSO) and raises the price target from $9.25 to $10.

April 30, 2024 | 10:43 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Ekso Bionics Holdings and raises the price target from $9.25 to $10.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong bullish sentiment towards the stock, suggesting a positive short-term impact on EKSO's stock price. The maintenance of a Buy rating alongside a raised price target indicates increased confidence in the company's future performance, likely leading to positive investor sentiment and potential stock price appreciation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100